Skip to main content

Animations

MJFF Publications

7781 - 7790 of 9117 Results
Title
Year
  • Year
  • 2021
  • 2023
  • 2023
  • 2023
  • 2023
  • 2021
  • 2021
  • 2021
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.109189
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02599-5
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-38782-7
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteins
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00564-3
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Oromandibular Dystonia: A Clinical Examination of 2,020 Cases
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.700714
    Citation Count: 36
  • Summary Details
    OPEN
    Title: The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2021.101191
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Contribution of rare variant associations to neurodegenerative disease presentation
    Journal Name: npj Genomic Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41525-021-00243-3
    Citation Count: 22
  • Summary Details
    OPEN
    Title: LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2303789120
    Citation Count: 74
  • Summary Details
    OPEN
    Title: The effects of AQP4 rs162009 on resting‐state brain activity in Parkinson's disease
    Journal Name: CNS Neuroscience & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/cns.14208
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.